Cellromax Science Co., Ltd. Logo

Cellromax Science Co., Ltd.

Develops health foods, derma-cosmetics, and OTC drugs for pharmacies and online channels.

471820 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
경기도 용인시 기흥구 구성로 357 D동 710호 (청덕동, 용인테크노밸리), 용인시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cellromax Science Co., Ltd. is a KOSDAQ-listed company specializing in the development, manufacturing, and distribution of health-oriented products. Its primary business divisions include health functional foods, derma-cosmetics, and over-the-counter (OTC) pharmaceuticals. The company focuses on creating differentiated products through dedicated research, using carefully selected natural-origin raw materials and optimal formulation science. Key product features include specialized prescriptions and user-friendly formulation technology. Cellromax Science distributes its products through pharmacies and direct-to-consumer online channels. The company was formerly known as Pharmacist & Health Co., Ltd. and rebranded in 2021.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Cellromax Science Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-12 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정 (분기배당)
Korean 8.1 KB
2025-09-12 00:00
Notice of Dividend Amount
중간(분기)배당을위한주주명부폐쇄(기준일)결정
Korean 5.5 KB
2025-09-01 00:00
Share Issue/Capital Change
감자완료
Korean 8.9 KB
2025-08-27 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.2 MB
2025-08-13 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(감자결정)
Korean 22.5 KB
2025-08-12 00:00
Share Issue/Capital Change
[기재정정]전환청구권행사 (제1회차)
Korean 11.8 KB

Automate Your Workflow. Get a real-time feed of all Cellromax Science Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Cellromax Science Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
StemRIM Inc. Logo
Developing regenerative medicines that use the body's own stem cells to treat intractable diseases.
Japan 4599
STENOCARE A/S Logo
Develops and distributes prescription medical cannabis oils in Northern Europe and Australia.
Denmark STENO
ST PHARM CO., LTD. Logo
A global CDMO specializing in APIs and RNA therapeutics for the gene therapy market.
South Korea 237690
Sugentech, Inc. Logo
Develops advanced in-vitro diagnostic systems for hospitals, clinics, and at-home use.
South Korea 253840
SUHEUNG CO.,LTD. Logo
Global manufacturer of capsules and contract manufacturing for pharma/nutraceutical industries.
South Korea 008490
Sumitomo Pharma Co., Ltd. Logo
R&D pharma creating medicines for oncology, psychiatry & neurology, focusing on Japan & the US.
Japan 4506
SunBio, Inc. Logo
Develops biopharmaceuticals and devices like artificial blood using proprietary PEGylation technology.
South Korea 067370
Swedish Orphan Biovitrum Logo
Develops innovative therapies for rare diseases in haematology, immunology, and specialty care.
Sweden SOBI
SymBio Pharmaceuticals Limited Logo
Acquires and commercializes specialty drugs for unmet needs in Japan and the Asia-Pacific region.
Japan 4582
SynAct Pharma Logo
Biotech developing oral therapies to resolve inflammation in diseases like rheumatoid arthritis.
Sweden SYNACT

Talk to a Data Expert

Have a question? We'll get back to you promptly.